Background
We have previously demonstrated the efficacy of lycopene against cardiovascular and neurological complications associated with obesity. However, its effect on anaemia and ionic disturbances associated with obesity remain unexplored; hence, this study.
Procedures
Obesity was induced with a Western-style diet. Thereafter, rats were distributed into five groups (n = 6): control, obese, obese + lycopene (20 mg/kg b.wt.), obese + lycopene (40 mg/kg b.wt.), and normal + lycopene (40 mg/kg b.wt.), for four weeks.
Findings
Obese rats had significantly (P < 0.001) reduced serum concentrations of Na+, Mg2+, and Cl− (by 31.8%, 24.1%, and 37.2%, respectively), whereas K+ and Ca2+ concentrations were significantly (P < 0.001) increased by over one-fold, compared to the control. Red blood cell count, haemoglobin, serum iron, and other blood indices were significantly (P < 0.001) reduced compared to the control, whereas serum hepcidin was elevated. Obese rats also presented insulin resistance, hallmarked by poor glucose tolerance, hyperinsulinemia, higher HOMA-IR, hyperglycaemia, and higher glycated haemoglobin concentrations. In the liver, we also observed upregulated TNFα expression and downregulated IRS-1 expression. The liver and kidneys activities of Na+/K+- and Ca2+/Mg2+-ATPases were inhibited in obese rats. However, treatment with lycopene alleviated obesity-induced ionic disturbances, improved haematological indices, improved insulin sensitivity and iron homeostasis, upregulated IRS-1 expression and ATPases activity, and downregulated TNFα expression, in a dose-dependent manner.
Conclusion
Our findings indicate that lycopene can protect against obesity-induced ionic disturbances and anaemia with improved insulin sensitivity, ATPases activities, and iron status as possible underlying mechanisms.